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Reactivation tuberculosis (TB) and Mycobacterium avium complex (MAC) disease are signif-
icant causes of morbidity in HIV infected patients, especially in resource-constrained set-
tings. These diseases are the most common AIDS-presenting illnesses in some countries.
Although morbidity and mortality have significantly decreased with the advent of Highly
Active Antiretroviral Therapy, significant challenges exist in treating patients, among them
overlapping medication toxicities, drug-drug interactions and the risk of developing
Immune Reconstitution Inflammatory Syndrome. Mycobacterial resistance to existing anti-
microbials continues to rise, further complicating the management of these patients and
presenting a public health challenge.
Solid organ and hematopoietic stem cell transplant recipients are also at increased risk of
developing TB and MAC disease. In addition, although patients with cellular immune
defects are perceived to be at higher risk for non-tuberculous mycobacterial infection, lim-
ited data exist on the frequency of these infections in this patient population. Incidence
may be influenced by the degree of immunosuppression and the types of immunosuppres-
sants used. Diagnosis is sometimes challenging, and the clinician needs to keep a high
index of suspicion to correctly diagnose the syndromes caused by these bacteria.
The author will review the epidemiology, clinical presentation, diagnostic methods and
principles of treatment of the most common mycobacteria that cause disease in HIV and
transplant recipients, and will discuss some of the nuances in the management of these
patients.
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